Metraipolis › archive › dc_92424ec2b2cb

Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis — Europe PMC PMID:42069794

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42069794
DOI
10.1038/s41598-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T19:35:56.279Z
SHA-256 of the archived text
839689f9957dad42311f0062cf75427d63803f31ba3cc7ae6ce6278dba0cca56
Stable URL of this page
https://metraipolis.com/documento/dc_92424ec2b2cb

How to cite

Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis — Europe PMC PMID:42069794 — Europe PMC (en), https://europepmc.org/article/MED/42069794 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_92424ec2b2cb (Metraipolis archive dc_92424ec2b2cb, sha256 839689f9957dad42311f0062cf75427d63803f31ba3cc7ae6ce6278dba0cca56)
BibTeX
@misc{dc92424ec2b2cb,
  title = {Arvanil reverses cisplatin resistance in ovarian cancer by activating HMOX1-driven ferroptosis — Europe PMC PMID:42069794},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42069794},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_92424ec2b2cb; sha256 839689f9957dad42311f0062cf75427d63803f31ba3cc7ae6ce6278dba0cca56},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42069794. Agents can read the archived copy with the MCP tool read_document.